GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (BSP:N1BI34) » Definitions » Pretax Margin %

Neurocrine Biosciences (BSP:N1BI34) Pretax Margin % : 38.47% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Neurocrine Biosciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Neurocrine Biosciences's Pre-Tax Income for the three months ended in Dec. 2023 was R$971 Mil. Neurocrine Biosciences's Revenue for the three months ended in Dec. 2023 was R$2,524 Mil. Therefore, Neurocrine Biosciences's pretax margin for the quarter that ended in Dec. 2023 was 38.47%.

The historical rank and industry rank for Neurocrine Biosciences's Pretax Margin % or its related term are showing as below:

BSP:N1BI34' s Pretax Margin % Range Over the Past 10 Years
Min: -940.6   Med: 5.9   Max: 17.6
Current: 17.6


BSP:N1BI34's Pretax Margin % is ranked better than
79.94% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 4.555 vs BSP:N1BI34: 17.60

Neurocrine Biosciences Pretax Margin % Historical Data

The historical data trend for Neurocrine Biosciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Pretax Margin % Chart

Neurocrine Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.90 10.20 8.95 14.37 17.60

Neurocrine Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.62 -24.57 26.86 23.18 38.47

Competitive Comparison of Neurocrine Biosciences's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Neurocrine Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurocrine Biosciences's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurocrine Biosciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Neurocrine Biosciences's Pretax Margin % falls into.



Neurocrine Biosciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Neurocrine Biosciences's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1627.224/9246.413
=17.60 %

Neurocrine Biosciences's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=971.14/2524.377
=38.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurocrine Biosciences  (BSP:N1BI34) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Neurocrine Biosciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurocrine Biosciences (BSP:N1BI34) Business Description

Traded in Other Exchanges
Address
12780 El Camino Real, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (BSP:N1BI34) Headlines

No Headlines